摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-methyl-3-oxazolo[5,4,b]pyridin-2-yl-phenyl)-carbamic acid prop-2-ynyl ester | 423754-92-1

中文名称
——
中文别名
——
英文名称
(4-methyl-3-oxazolo[5,4,b]pyridin-2-yl-phenyl)-carbamic acid prop-2-ynyl ester
英文别名
prop-2-ynyl N-[4-methyl-3-([1,3]oxazolo[5,4-b]pyridin-2-yl)phenyl]carbamate
(4-methyl-3-oxazolo[5,4,b]pyridin-2-yl-phenyl)-carbamic acid prop-2-ynyl ester化学式
CAS
423754-92-1
化学式
C17H13N3O3
mdl
——
分子量
307.309
InChiKey
YKNAGCSZZLCETP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    77.2
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Benzoxazole LPAAT-B inhibitors and uses thereof
    申请人:CELL THERAPEUTICS, INC.
    公开号:US20020107269A1
    公开(公告)日:2002-08-08
    The invention relates to benzoxazoles and the use thereof to inhibit lysophosphatidic acid acyltransferase &bgr; (LPAAT-&bgr;) activity. The invention further relates to methods of treating cancer using said benzoxazoles. The invention also relates to methods for screening for LPAAT-&bgr; activity.
    该发明涉及苯并噁唑及其用途,用于抑制溶磷脂酸酰基转移酶β(LPAAT-β)活性。该发明还涉及使用所述苯并噁唑治疗癌症的方法。该发明还涉及筛选LPAAT-β活性的方法。
  • [EN] BENZOXAZOLE LPAAT- beta INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS BENZOXAZOLES DE LPAAT- DOLLAR G(B) ET UTILISATIONS ASSOCIEES
    申请人:BONHAM LYNN
    公开号:WO2002036580A2
    公开(公告)日:2002-05-10
    The invention relates to benzoxazoles of the following Formula, wherein the variables are defined in the claims and the use thereof to inhibit lysophosphatidic acid acyltransferase β (LPAAT-β) activity. The invention further relates to methods of treating cancer using said benzoxazoles. The invention also relates to methods for screening to LPAAT-β activitiy.
  • [EN] BENZOXAZOLE LPAAT- BETA INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS BENZOXAZOLES DE LPAAT- DOLLAR G(B) ET UTILISATIONS ASSOCIEES
    申请人:——
    公开号:WO2002036580A9
    公开(公告)日:2003-02-13
    [EN] The invention relates to benzoxazoles of the following Formula, wherein the variables are defined in the claims and the use thereof to inhibit lysophosphatidic acid acyltransferase beta (LPAAT- beta ) activity. The invention further relates to methods of treating cancer using said benzoxazoles. The invention also relates to methods for screening to LPAAT- beta activitiy.
    [FR] L'invention concerne des benzoxazoles et l'utilisation de ceux-ci dans l'inhibition de l'activité de l'acide lysophosphatidique de l'acyltransférase beta (LPAAT- beta ). L'invention concerne en outre des méthodes de traitement de cancer mettant en oeuvre ces benzoxazoles. L'invention concerne enfin des méthodes de criblage de l'activité de LPAAT- beta .
查看更多